F. Daniel Ramirez, MD, is a cardiac electrophysiologist and clinician scientist in the Division of Cardiology at the University of Ottawa Heart Institute. He is also an assistant professor in the Faculty of Medicine at the University of Ottawa.
Dr. Ramirez holds a Bachelor of Science Degree in Biochemistry from the University of Ottawa and an MD from Queen’s University. He completed residencies in internal medicine and cardiology as well as a Master of Science Degree in Epidemiology and a combined clinical and research fellowship in cardiac electrophysiology at the University of Ottawa. He then completed additional training in cardiac electrophysiology as a Banting Postdoctoral Fellow at the Hôpital Cardiologique du Haut-Lévêque and L’Institut de Rythmologie et Modélisation Cardiaque (LIRYC) in Bordeaux, France before returning to Ottawa to join the Heart Institute.
Dr. Ramirez is currently a member of the National Institutes of Health (NIH) Advisory Committee to the Director Working Group on Enhancing Rigor, Transparency, and Translatability in Animal Research. He was recently appointed to the Editorial Board of the Canadian Journal of Cardiology.
Dr. Ramirez has been awarded the Canadian Institutes of Health Research (CIHR) Banting Postdoctoral Fellowship, Royal College of Physicians and Surgeons of Canada Detweiler Travelling Fellowship, Heart Rhythm Society Travel Scholarship, Cardiac Arrhythmia Network of Canada Discovery Award, Canadian Society for Clinical Investigation/CIHR Excellence in Resident Research Award, and CIHR Frederick Banting & Charles Best Canada Graduate Scholarship (CGS-M), among others. Locally, he has also received the Ottawa Region Cardiovascular Research Trainee of the Year Award and Ernest & Margaret Ford Research Fellowship, as well as the Best Thesis Award for the MSc in epidemiology from the University of Ottawa.
Dr. Ramirez’s research interests focus on the diagnosis and treatment of atrial and ventricular tachyarrhythmias, understanding the impact of percutaneous ablative therapies on cardiac physiology, and improving the predictive ability of translational research.
- Ramirez FD, Reddy VY, Viswanathan R, Hocini M, Jaïs P. Emerging technologies for pulmonary vein isolation. Circulation Research 2020;127(1):170-183
- Ramirez FD, Jung R, Motazedian P, Perry-Nguyen D, Di Santo P, MacDonald Z, Clancy AA, Labinaz A, Promislow S, Simard T, Provencher S, Bonnet S, Graham ID, Wells GA, Hibbert B. Journal initiatives to enhance preclinical research: analyses of Stroke, Nature Medicine, Science Translational Medicine. Stroke 2020;51(1):291-299
- Ramirez FD, Sadek MM, Boileau I, Cleland M, Nery PB, Nair GM, Redpath CJ, Green MS, Davis DR, Charron K, Henne J, Zakutney T, Beanlands RSB, Hibbert B, Wells GA, Birnie DH. Evaluation of a novel cardioversion intervention for atrial fibrillation: the Ottawa AF cardioversion protocol. Europace 2019;21(5):708-715
- Ramirez FD, Motazedian P, Jung RG, Di Santo P, MacDonald ZD, Moreland R, Simard T, Clancy AA, Russo JJ, Welch VA, Wells GA, Hibbert B. Methodological rigor in preclinical cardiovascular studies: targets to enhance reproducibility and promote research translation. Circulation Research 2017;120(12):1916-1926
- Ramirez FD, Motazedian P, Jung RG, Di Santo P, MacDonald Z, Simard T, Clancy AA, Russo JJ, Welch V, Wells GA, Hibbert B. Sex bias is increasingly prevalent in preclinical cardiovascular research: implications for translational medicine and health equity for women. A systematic assessment of leading cardiovascular journals over a 10-year period. Circulation 2017;135(6):625-626
- Ramirez FD, Hibbert B, Simard T, Pourdjabbar A, Wilson KR, Hibbert R, Kazmi M, Hawken S, Ruel M, Labinaz M, O’Brien ER. Natural history and management of aortocoronary saphenous vein graft aneurysms: a systematic review of published cases. Circulation 2012;126 (18):2248-225